Sodium Replacement in Hyponatremia
The recommended treatment for sodium replacement in hyponatremia should be tailored based on symptom severity, acuity of onset, and volume status, with hypertonic saline (3%) reserved for severe symptomatic cases and a correction rate not exceeding 8 mmol/L in 24 hours to prevent osmotic demyelination syndrome. 1
Assessment of Hyponatremia
Before initiating treatment, determine:
Symptom severity:
Volume status:
Duration:
Treatment Algorithm
1. Severe Symptomatic Hyponatremia (Mental status changes, seizures)
Administer 3% hypertonic saline: 1
- Initial goal: Correct 6 mmol/L over 6 hours or until severe symptoms resolve
- Total correction should not exceed 8 mmol/L in 24 hours
- Calculate sodium deficit: Desired increase in Na (mEq) × (0.5 × ideal body weight)
- Monitor serum sodium every 2 hours in ICU setting
Correction rate: 1
- If 6 mmol/L is corrected in first 6 hours, limit further correction to 2 mmol/L in the following 18 hours
- Rapid correction >1 mmol/L/hour should only be used for severely symptomatic and/or acute hyponatremia
After symptom improvement: 1
- Transition to treatment for mild symptoms or asymptomatic protocol
- Continue monitoring serum sodium levels closely
2. Mild Symptomatic Hyponatremia
For SIADH: 1
- Fluid restriction to 1 L/day
- Monitor sodium every 4 hours initially
- If no response: Add oral sodium chloride 100 mEq TID
- Consider high protein diet
For Hypovolemic Hyponatremia: 1, 2
- Normal saline infusion to expand plasma volume
- Correct underlying cause of volume depletion
For Hypervolemic Hyponatremia (e.g., cirrhosis): 1
- Fluid restriction to 1-1.5 L/day for severe hyponatremia (Na <125 mmol/L)
- Discontinue diuretics if they're contributing to hyponatremia
- Reserve hypertonic saline for severely symptomatic patients only
3. Chronic Asymptomatic Hyponatremia
Avoid rapid correction: 1
- Chronic hyponatremia should be corrected slowly to prevent osmotic demyelination syndrome
- Target correction rate <8 mmol/L per 24 hours
Treat underlying cause: 3
- SIADH: Fluid restriction, salt tablets, or vaptans in select cases
- Cirrhosis: Fluid restriction, albumin in specific scenarios
- Medication-induced: Adjust or discontinue causative medications
Special Considerations
Cirrhosis with Hyponatremia
Hypovolemic hyponatremia: 1
- Requires plasma volume expansion with normal saline
- Correct causative factors
Hypervolemic hyponatremia: 1
- Fluid restriction to 1-1.5 L/day for severe hyponatremia (Na <125 mmol/L)
- Hypertonic saline should be limited to severely symptomatic cases or pre-liver transplant patients
- After initial correction (5 mmol/L in first hour for severe symptoms), limit to <8 mmol/L per day
Neurosurgical Patients
For Cerebral Salt Wasting (CSW): 1
- Treatment with hypertonic saline and fludrocortisone for severe symptoms
- Avoid fluid restriction which can worsen outcomes in subarachnoid hemorrhage patients
For SIADH in neurosurgical setting: 1
- Primary treatment is fluid restriction unless severely symptomatic
- Hypertonic saline for severe symptoms or subarachnoid hemorrhage patients at risk of vasospasm
Monitoring and Safety
Risk of overcorrection: 4
- Higher in severely symptomatic patients (38% vs 6% in moderate symptoms)
- Monitor diuresis closely as it correlates with sodium overcorrection
- Consider reducing bolus volume and reevaluating before repeating infusions
Prevention of osmotic demyelination: 3, 2
- Never exceed correction of 10 mmol/L in first 24 hours
- For chronic hyponatremia, slower correction is safer
- If overcorrection occurs, consider administering hypotonic fluids (D5W) to re-lower sodium levels
Oral sodium replacement option: 5
- In selected cases where IV hypertonic saline is not feasible, hourly oral sodium chloride tablets may be considered
- Calculate dose to deliver equivalent of 0.5 mL/kg/h of 3% NaCl
- Requires very close monitoring of serum sodium levels